SHARE

IV Vitamin C Puts Metastatic Liver Cancer into Remission: In this remarkable new case study from Korea, intravenous vitamin C at a dose of 70 grams per infusion (given two times weekly) has apparently cured an elderly woman of her liver cancer. The 74 year old woman had primary liver cancer (HCC) which had metastasized to her lungs and lymph nodes and was not being helped with conventional treatments. But after 10 months of treatment with IV vitamin C, the metastases had disappeared and the primary liver tumor had shrunk down in size. After another year of vitamin C therapy, and three more rounds of conventional treatment (transarterial chemoembolization — called “TACE”), PET-CT scans showed the liver tumor had completely disappeared.



“We describe a case of regression of multiple pulmonary metastases after treatment with high-dose vitamin C, which enabled a subsequent trial of TACE, eventually leading to complete remission of the primary hepatocellular carcinoma. Notably, intravenous vitamin C administration has an advantage in terms of safety compared to other conventional cancer therapies. Our patient did not show any complications or serious side effects, except for mild thirst. Although there is controversy over the effect of vitamin C on cancer, intravenous administration of high-dose vitamin C could be attempted in patients who refuse conventional therapy. Also, we hope to find a common denominator in accumulated case reports that might offer clues to which cases vitamin C administration could be an effective cancer therapy.”

Such a recovery from metastatic liver cancer is extremely rare. But this is not the first time that intravenous vitamin C — either alone or together with conventional medicine — has helped cancer patients. Multiple clinical trials have shown this treatment to reduce tumor markers in 77% of prostate cancer patients and 73% of breast cancer patients, reduce inflammation (an important marker for survival) and dramatically improve quality of life (feeling of well being). And a recent trial showed that IV vitamin C together with chemo more than doubled survival time of pancreatic cancer patients compared to chemo alone.



Study:

Post Source